Gaming

Netmarble's New Game 'SOL: enchant' Tops Sales Charts on Both Major App Stores

About 22 hours after its launch on the 18th Google and Apple Top Sales Charts on Korea’s Two Major App Stores, Enjoying Early Success

An Yu-ri
2026-06-19 14:20:45
[Edaily Reporter Ahn Yu-ri] #Netmarble announced on the 19th that its new game, “SOL: enchant,” topped the sales charts on both major domestic app stores less than a day after its release on the 18th.


Following its launch at 12:00 p.m. on the 18th, ‘SOL: enchant’ reached the top of the Apple App Store revenue charts in about 8 hours and subsequently climbed to the top of the Google Play Store revenue charts as well, dominating both major app stores.

To thank users for their support, Netmarble is distributing special rewards to celebrate topping the sales charts on both platforms: 10 “High-Grade God Armor Summon Tickets,” 10 “High-Grade Spirit Summon Tickets,” and 5 “Growth Potions (20%).” Users can claim these rewards from their in-game mailbox after logging in.

Additionally, as part of the “SOL: enchant” launch event, the drop rates for all boss monster rewards have been tripled to provide more generous rewards, and the first player on each server to reach Level 50 will receive the Hero-grade “Ring of Baltaros.”

Meanwhile, “SOL: enchant” is a new MMORPG that introduces a unique “Divine Authority” system under the motto of “Omniscient MMORPG.” Developed by Altnine—a new studio led by the core team behind “Lineage M”—and published by Netmarble, the game supports both PC and mobile platforms.

Economy

Corporation

IT·Science

Economy

"Why Should I Buy That Apartment for You?"... Will It Take 30 Years for Gen Z and Millennials to Buy a Home in Seoul?

(Photo: Blind) One of the concerns facing the Lee Jae-myung administration is the decline in support among young people. According to Gallup Korea’s presidential job approval ratings, the approval…
2026-10-04 12:00:03

Corporation

GI Innovation and G2G Bio Jump 20% on Hopes for a Licensing Deal [K-bio pulse]

The KRX Health Care Index rose 4.53% from the previous session on Oct. 1, signaling a rare tailwind for South Korea’s pharmaceutical and biotech sector. Among the gainers, GIInnovation and G2GBio drew…
2026-10-03 07:22:03